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Abstract
The chemoselective and complementary Pd-and Cu-catalyzed N-arylation of 2-
aminobenzimidazoles is described. Selective N-arylation of the amino-group was achieved with a
Pd-catalyzed method, while selective N-arylation of azole nitrogen was achieved with a Cu-
catalyzed procedure. The utility of these complementary sets of conditions is demonstrated in
several two-step, selective syntheses of di-arylated aminoazoles.
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Transition-metal catalyzed heteroatom-arylation reactions are emerging as valuable tools in
organic synthesis, fuelled by the identification of more efficient catalyst systems with
increased substrate scopes.[1] The synthetic utility of these transformations is increased if
catalysts are both highly reactive and selective. This is particularly important for substrates
with multiple heteroatom sites capable of undergoing reaction. Furthermore, the
development of complementary sets of catalysts or conditions for the selective arylation of
substrates possessing multiple nucleophilic sites enables the rapid, protecting group-free
generation of molecular complexity with minimal synthetic manipulations. In this context,
we have developed sets of procedures for the Pd- and Cu-catalyzed chemoselective arylation
of aminobenzamides,[2a] 5-aminoindole,[2a] 4-(2-aminoethyl)aniline,[2a] amino alcohols,[2b]
oxindoles[2c] and aminophenols. [2d]
During our work on the N-arylation of nitrogen-containing heterocycles,[3] we became
interested in the use of 2-aminobenzimidazoles as potential substrates for chemoselective N-
arylation reactions. Both N1-aryl-2-aminobenzimidazoles and 2-arylaminobenzimidazoles
are found in a variety of medicinally important compounds including integrin α4β1
antagonists,[4] mTOR inhibitors,[5] aurora kinase inhibitors,[6] Tie-2 kinase inhibitors,[7] Ca
channel blockers,[8] and CXCR2 antagonists.[9 Thus, the selective syntheses of both of these
isomers from a common core structure represent attractive alternatives to other previously-
employed routes[10–11] and could provide rapid access to a diverse array of potentially
bioactive 2-aminobenzimidazole derivatives (Scheme 1).
While the efficient Cu-[12] and Pd-catalyzed[13] N1-arylations of some benzimidazole
derivatives with aryl halides have been described, the chemoselective N-arylation of
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unprotected 2-aminobenzimidazoles with aryl halides has received little attention. [14–16]
Potential challenges of such an approach include the formation of regioisomers and/or poly-
arylated products due to the presence of three adjacent nucleophilic nitrogens (N1, N3 and
C2-amino group), as well as the tautomeric nature of 2-aminobenzimidazoles. Herein, we
report the successful development of an orthogonal set of Pd- and Cu-catalyzed
chemoselective conditions for the N-arylation of unprotected 2-aminobenzimidazoles and
related aminoazoles.
We initiated our investigation by examining the Pd-catalyzed coupling of 2-
aminobenzimidazole and bromobenzene (Table 1). With Pd2(dba)3 (0.1 mol%), L1 (0.2 mol
%), and K3PO4, the N-arylation went smoothly to give 2-anilinobenzimidazole 1a in 92%
yield and without formation of regioisomer 1b or poly-arylated products (entry 1). The use
of other biaryl phosphine ligands (L2–L4) provided low yields of product under these
conditions. Replacing K3PO4 with other bases also resulted in lower yield of the product
(entries 5–6).
Turning our attention to finding conditions for the selective formation of the the N1-arylated
product (2a), we found that reactions with a Cu-catalyst system (iodobenzene/
bromobenzene, CuI, L5,[17] and Cs2CO3) were completely chemoselective, providing no
trace either of regioisomer 1a or of any poly-arylated products (entries 7–8). The use of
other ligands (L6–L8) and bases did not alter this chemoselectivity, but rather gave lower
yields of 1b (entries 9–13). Thus, complete selectivity and complementarity can be achieved
using Pd- and Cu-based catalyst systems.
We next explored the scope of the Pd-catalyzed selective N-arylation of aminoazoles, and
found that a variety of 2-aminobenzimidazoles and 2-aminoimidazole could be coupled
chemoselectively with both electron-rich and electron-poor aryl halides, as well as with an
ortho-substituted aryl halide (Table 2, 1b–1h).[18] For 3-amino-5-alkylpyrazoles the primary
amino groups were also selectively and efficiently arylated using 0.2–0.5 mol% catalyst.
Though the selective Pd-catalyzed N-arylation of 3-aminopyrazoles has been previously
reported, relatively high catalyst loadings (5 mol% Pd and 10 mol% L4) and the use of a
strong base (NaOtBu) were required.[13a]
The scope of the Cu-catalyzed N1-selective arylation was also investigated (Table 3).
Reactions of 2-aminobenzimidazoles and 2-aminoimidazole with a variety of functionalized
aryl iodides gave N1-arylated products 2b–2f and 2i selectively and in good yields. The N-
arylation of unsymmetrical 2-amino-4-methylbenzimidazole reacted at the less sterically-
hindered N1-position to provide 2g. Both electron-rich, 2e, g and electron-deficient aryl
halides reacted smoothly to give products in high yield. Lastly, reactions of 2-
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alkylaminobenzimidazoles gave N1-arylated products 2j and 2k in good yields. Not
surprisingly, the process showed good functional group compatibility.
Having established a complementary set of Pd- and Cu-catalyzed chemoselective arylation
methods, we sought to apply our methods to selective two-step syntheses of
diarylaminoazoles from unprotected aminoazoles using sequential Pd- and Cu-catalyzed
reactions (or vice versa). Parent 2-aminobenzimidazole could be selectively arylated via an
initial Pd-catalyzed N-arylation of 2-aminobenzimidazole, followed by a subsequent Cu-
catalyzed arylation to give 3. Diarylated 3-aminoindazole 4 was prepared via a Cu-catalyzed
reaction of 3-aminoindazole, followed by arylation via the Pd-catalyzed method. In both
cases, the reaction order was important. In the first case, only a trace amount of 3 was
obtained when the Pd-catalyzed system was used as the second step. For the synthesis of 4,
the use of a Pd-catalyst for the first arylation of 3-amioindazole gave a mixture of mono-
and di-arylated products.[19]
In summary, we have developed an orthogonal set of Pd- and Cu-catalyzed N-arylations of
2-aminobenzimidazoles and related aminoazoles. Selective N-arylation of the primary
amino-group of 2-aminobenzimidazoles was achieved via Pd-catalyzed methods, while
selective N-arylation of the azole nitrogen was achieved with Cu-catalysis. These general
protocols are compatible with a variety of aryl halides and give facile access to an array of
both isomers of N-arylaminoazoles from common aminoazole precursors.
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Scheme 1.
Chemoselective arylation of 2-aminobenzimidazole
Ueda and Buchwald Page 5
Angew Chem Int Ed Engl. Author manuscript; available in PMC 2013 October 08.
$watermark-text
$watermark-text
$watermark-text
Scheme 2.
Selective syntheses of diarylaminoazoles
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Table 2
Scope of the Pd-catalyzed N-arylation[a]
[a]
aryl halide (1 mmol), aminoazole (1.1 mmol), K3PO4 (1.5 mmol), Pd2(dba)3 (0.1–0.5 mol%), L1 (0.2–1 mol%), t-BuOH (1.5 mL), 120 °C, 5 h.
Yield of isolated product, average of two runs.
[b]2-aminoimidazole sulfate (1.1 mmol), K3PO4 (2.5 mmol) and DMF were used.
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Table 3
Scope of the Cu-catalyzed N-arylation[a]
[a]
aryl halide (1 mmol), aminoazole (1.1 mmol), Cs2CO3 (1.5 mmol), CuI (10 mol%), L5 (15 mol%), t-BuOH (1.5 mL), 90–110 °C, 16 h. Yield of
isolated product, average of two runs.
[b]0.5 mmol scale.
[c]2-aminoimidazole sulfate (1.1 mmol), Cs2CO3 (2.5 mmol) were used.
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